Lumida
/ADMA
⌘K
ADMA Biologics Inc

ADMA Biologics Inc

ADMA
$9.39USD+0.54%+0.05 today

MARKET CAP

2.1B

P/E (TTM)

13.8x

FWD P/E

DAY RANGE

$9 – $9

52W RANGE

$7
$20

AI Summary

Stalk
Buy NowMedium

ADMA remains below its long-term 200 DMA, confirming a structural downtrend, but has stabilized above rising 9/20/50 EMAs in a Stage 2 repair context. The medium-term bias is bullish after a consolidation breakout and EMA alignment, and the current pullback into the EMA cluster offers a favorable buy zone for continuation participation.

  • Q2 2026 revenue $124.4M (+2% YoY) driven by ASCENIV.
  • ASCENIV sales hit $102.9M (+24% YoY), stabilizing sequential demand.
  • Securities class action alleges fraud, undermining transparency and trust.
Full analysis →

Buying

6

institutions

Selling

9

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY38.36 M321.04 M+1.52 M-3.3%0.00%
DF

Duquesne Family Office LLC

Q2 2026

BUY2.78 M23.30 M+1.24 M+67.3%0.45%
CA

Citadel Advisors LLC

Q2 2026

SELL1.62 M13.56 M+-4.63 M-75.9%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY1.53 M12.77 M+1.01 M+175.3%0.00%
MM

Millennium Management LLC

Q2 2026

SELL1.15 M9.66 M+-2.28 M-68.8%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL652.53 K5.46 M+-610.10 K-52.0%0.01%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL499.13 K4.18 M+-2.81 M-86.0%0.00%
BA

Bridgewater Associates, LP

Q2 2026

SELL401.06 K3.36 M+-71.05 K-21.1%0.01%
JC

Jpmorgan Chase & Co

Q2 2026

SELL276.72 K2.40 M+-236.20 K-48.8%0.00%
JH

Janus Henderson Group Plc

Q1 2026

SELL196.52 K1.77 M+-3.74 M-97.5%0.00%
PA

Perceptive Advisors LLC

Q2 2026

SELL113.77 K952.21 K+-820.70 K-88.7%0.01%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY68.90 K576.66 K+48.10 K+207.8%0.00%
MG

Man Group Plc

Q2 2026

BUYNEW22.05 K184.58 K+22.05 K+0.0%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY5.41 K45.26 K+1.98 K+46.7%0.00%
VI

Voloridge Investment Management, LLC

Q2 2026

SELL0.000.00+-296.46 K-100.0%0.00%